Paid Clinical Trials Kent

Discover 932 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 932

TTFields & PembrolizumabLUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Recruiting

PHASE3

Sponsor:

NovoCure GmbH

Location:

Auburn WA, Tacoma WA, Puyallup WA, Gig Harbor WAshow 28 more

Code:

NCT06216301

Conditions

Metastatic Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NovoTTF-200T

Pembrolizumab

Platinum based chemotherapy

Observational StudyC-Brace Prospective Registry

Recruiting

Sponsor:

Otto Bock Healthcare Products GmbH

Location:

Renton WA, Everett WA, Spokane WA, Saint George UTshow 47 more

Code:

NCT04640584

Conditions

Pareses

Lower Extremity

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

C-Brace

Thrombectomy TrialProximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Recruiting

PHASE3

Sponsor:

Mercy Health Ohio

Location:

Renton WA, Sacramento CA, San Francisco CA, Salt Lake City UTshow 29 more

Code:

NCT05611242

Conditions

Acute Ischemic Stroke

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

MT+CAS with IV-AP

MT+CAS with PO-AP

MT+CAT with PO-AP

Observational StudyCGMIS 48-hour Feasibility Study

Recruiting

Sponsor:

Pacific Diabetes Technologies

Location:

Renton WA

Code:

NCT05562206

Conditions

Type1diabetes

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

CGMIS (Continuous Glucose Monitoring Infusion Set)

TirzepatideA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Renton WA, Redmond WA, Missoula MT, Idaho Falls IDshow 27 more

Code:

NCT06914895

Conditions

Type 1 Diabetes

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Placebo

Eversense CGMEnhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

Recruiting

Sponsor:

Senseonics, Inc.

Location:

Renton WA, Idaho Falls ID, Escondido CA, San Antonio TX

Code:

NCT05131139

Conditions

Diabetes Mellitus

Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 2

Eligibility Criteria

Sex: All

Age: 14+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring System

LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Renton WA, Bellevue WA, Medford OR, Sacramento CAshow 29 more

Code:

NCT06074562

Conditions

Diabetic Peripheral Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3556050

Placebo

AZD9550 & AZD6234A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Recruiting

PHASE2

Sponsor:

AstraZeneca

Location:

Renton WA, Surrey, Medford OR, Meridian IDshow 39 more

Code:

NCT06862791

Conditions

Obesity or Overweight

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AZD9550

AZD6234

Placebo comparator

Tirzepatide & IxekizumabA Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Burien WA, Bellevue WA, Portland OR, Reno NVshow 34 more

Code:

NCT06857942

Conditions

Psoriasis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

AGA2118A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women with Low Bone MasS (ARTEMIS)

Recruiting

PHASE2

Sponsor:

Angitia Biopharmaceuticals

Location:

Burien WA, Missoula MT, Albuquerque NM, Tucson AZshow 3 more

Code:

NCT06577935

Conditions

Postmenopausal Osteoporosis

Eligibility Criteria

Sex: Female

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

AGA2118

Placebo